Cow-itch
StarMucuna pruriens
Synonyms: Labradia pruriens, Dolichos pruriens, Negretia pruriens, Hornera pruriens, Carpopogon pruriens, Mucuna prurita, Stizolobium pruriens, Stizolobium pruritum
Western Herbalism Properties
Gallery
Botanical Description
Mucuna pruriens, called cow-itch, velvet bean or kapikacchu, is a vigorous annual to short-lived perennial climbing legume of the Fabaceae family native to tropical Africa and Asia and naturalised throughout the tropics. It typically reaches 3 to 15 m in length, with twining, finely pubescent stems. The trifoliolate leaves bear broadly ovate to rhombic leaflets 7 to 15 cm long, the terminal leaflet symmetric and the laterals strongly asymmetric, all softly pubescent below. Showy axillary pendulous racemes 15 to 32 cm long carry numerous papilionaceous flowers with dark purple, lavender or white standards and prominent curved keels. The fruit is a strongly curved, longitudinally ribbed legume 4 to 13 cm long densely covered with stiff, reddish-orange irritant trichomes that contain mucunain and cause intense itching on contact (hence the common name cow-itch). Each pod contains 4 to 6 large, ovoid, glossy, mottled brown to black seeds.
Active Constituents
L-DOPA (levodopa)
Non-protein amino acid / catecholamine precursorConcentration: ~4-6% of seed
The dopamine precursor L-DOPA is the principal active constituent, responsible for the plant's anti-parkinsonian effect; Mucuna seed powder produces a faster onset and, per gram of L-DOPA, comparable to superior motor benefit versus standard levodopa/carbidopa in trials.
Serotonin and 5-hydroxytryptophan (5-HTP)
Indoleamine / tryptophan derivativesConcentration: Present in seed and trichomes
Serotonin (concentrated in the stinging hairs) accounts for much of the intense itch of the pods; trace tryptamines add to the plant's neuroactive profile.
Mucunain and proteolytic components of trichomes
Cysteine protease / itch-inducing proteinConcentration: In the loose stinging hairs of the pod
Mucunain in the trichomes activates itch receptors (PAR-2/PAR-4) and, with serotonin, causes the severe pruritus that gives the plant the name “cow-itch.”
Tetrahydroisoquinoline and β-carboline alkaloids
AlkaloidsConcentration: Minor seed constituents
Minor alkaloids may contribute additional, non-L-DOPA neuroprotective and antioxidant effects proposed to explain benefits beyond L-DOPA content alone.
Tryptamine and dopamine
Biogenic aminesConcentration: Trace amounts in seed
Free dopamine and tryptamine occur alongside L-DOPA, adding to the seed's catecholaminergic activity.
Ursolic acid and phytosterols (β-sitosterol)
Triterpenoid / sterolsConcentration: Minor lipophilic constituents
Contribute to reported antioxidant and general tonic (Ayurvedic “vajikarana”) properties of the seed.
⚠ Drug Interactions
Levodopa / carbidopa and other L-DOPA-containing drugs
Mucuna seed delivers 4-6% L-DOPA, so combining it with prescription levodopa adds to the total L-DOPA dose and can cause excessive dopaminergic stimulation, nausea and dyskinesia.
Clinical note: Do not add to prescription levodopa without physician supervision and dose adjustment; used clinically as an alternative source of L-DOPA, not an add-on.
Non-selective MAO inhibitors (phenelzine, tranylcypromine) and MAO-B inhibitors (selegiline, rasagiline)
MAO inhibitors block breakdown of dopamine and other monoamines; a surge of L-DOPA-derived dopamine can precipitate hypertensive crisis and serotonergic toxicity.
Clinical note: Avoid combining Mucuna with MAOIs; hypertensive crisis with levodopa plus non-selective MAOIs is a documented, potentially life-threatening reaction.
Antihypertensive drugs
Levodopa can lower blood pressure and cause orthostatic hypotension; Mucuna may add to the effect of antihypertensive medication.
Clinical note: Monitor for additive drops in blood pressure and dizziness on standing.
Antipsychotics / dopamine antagonists (metoclopramide, haloperidol)
Dopamine-antagonist drugs oppose the dopaminergic action of Mucuna's L-DOPA, and Mucuna may reduce their efficacy, mirroring the well-known levodopa-antipsychotic interaction.
Clinical note: Expect reduced effect of either agent when co-administered; avoid in patients requiring dopamine blockade.
Preparation Methods
Seed powder (Ayurvedic kapikacchu / churna)
Parts: Seeds (deitched)
Cleaned, roasted or boiled and dried seed is powdered and taken in measured doses; in Parkinson's trials 15-30 g of standardised preparation delivered a therapeutic L-DOPA dose. Because L-DOPA content is high and variable, use only standardised products under professional guidance; not for use in pregnancy, psychosis, or with the drugs listed above.
Detoxified seed decoction/paste (traditional)
Parts: Seeds
Traditional Ayurvedic processing (soaking, boiling and drying) reduces irritants before the seed is used as a nervine tonic and aphrodisiac (vajikarana). Adequate processing is essential to lower anti-nutrients.
Caution - stinging pod hairs
Parts: Pod trichomes
The loose hairs (trichomes) covering the pods contain mucunain and serotonin and cause severe itching, dermatitis and eye irritation on contact; pods must be handled with protection and the hairs removed before any medicinal use of the seed.
Clinical Studies
Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study
In eight Parkinson's patients, a 30 g Mucuna preparation gave a faster onset of effect (34.6 vs 68.5 min) and ~21.9% longer “on” time than standard levodopa/carbidopa, with lower dyskinesia scores, despite higher peak L-DOPA plasma levels.
Mucuna pruriens Treatment for Parkinson Disease: A Systematic Review of Clinical Trials
Five trials (1995-2024; 108 participants) showed consistent motor improvement (e.g. UPDRS-III falling from 18.2 to 9.8), faster onset and longer “on” duration than standard levodopa, and fewer adverse events with no reported dyskinesia, while calling for larger confirmatory trials.
Historical Texts
Ayurveda (Charaka Samhita and later nighantus) - kapikacchu / atmagupta
Classical Indian medicine (c. 1st millennium BCE onward)References
- Lampariello LR, Cortelazzo A, Guerranti R, Sticozzi C, Valacchi G. The Magic Velvet Bean of Mucuna pruriens . Journal of Traditional and Complementary Medicine (2012) [DOI]
- Katzenschlager R, Evans A, Manson A, et al.. Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study . Journal of Neurology, Neurosurgery & Psychiatry (2004) [DOI]
- Hammoud F, Ismail A, Zaher R, El Majzoub R, Abou-Abbas L. Mucuna pruriens treatment for Parkinson disease: a systematic review of clinical trials . Parkinson's Disease (2025) [DOI]
This information is for educational purposes only and is not intended to replace professional medical advice. Always consult a qualified healthcare provider before using any herbal remedy, especially if you are pregnant, nursing, or taking medications.
📝 Notes
Public notes from the community and your own private notes on Cow-itch.
No notes yet.